Table 1. Characteristics of biopsy and residual triple negative breast tumor samples.

BIOPSY #	Neoadjuvant Treatments	Residual Tumors/size
1	T, dd AC	NRT
2	T + Cisp	NRT
3	T, AC	RT—1.6 mm
4	dd AC + T	RT—2 mm
5	T + Carb, AC	NRT
6	dd AC + Abrax	RT—26 mm
7	AC and T	RT—27 mm
8	T + Cisp	NRT
9	AC + T	RT—35 mm
10	dd AC-T	RT—0.5 mm
11	dd AC-T	RT—7 and 5 mm foci
12	Cisp, T, AC	RT—14 mm
13	Cisp, AC	NRT
14	Abrax, AC	NRT
15	dd AC, T/Carb	NRT/NA
16	dd AC-T	RT—3 mm
17	Xeeloda	NM
18	dd AC-T	NRT
19	BRE1440, Cisp	RT—25 mm
20	dd AC-T	NRT
21	T, AC	RT—37 & 17 mm foci
22	T, AC	RT—7 mm

NRT = No Residual Tumor; RT = Residual Tumor; NM = No mastectomy; NA = No tumor sample available; T = Taxol; AC = Adriamycin and Cytoxan; Cisp = Cisplatin; Carb = Carboplatin; dd AC = dose-dense Adriamycin; Abrax = Abraxane; Xeloda = Capecitabine; BRE1440